Stella Diagnostics, Inc. (SLDX)
OTCMKTS · Delayed Price · Currency is USD
0.0051
0.00 (0.00%)
At close: Jul 6, 2026
Stella Diagnostics Market Cap
Stella Diagnostics has a market cap or net worth of $1.54 million as of July 9, 2026. Its market cap has decreased by -96.06% in one year.
Market Cap
1.54M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since July 7, 2008, Stella Diagnostics's market cap has increased from 15.00 to 1.54M, an increase of 10,251,086.67%. That is a compound annual growth rate of 89.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 1.54M | -91.10% |
| Dec 23, 2024 | 17.27M | 29.13% |
| Dec 29, 2023 | 13.37M | -44.17% |
| Dec 20, 2022 | 23.95M | -38.61% |
| Dec 30, 2021 | 39.02M | -11.01% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioqual | 29.07M |
| Aspira Women's Health | 18.27M |
| Longduoduo Company | 15.31M |
| Psychemedics | 15.24M |
| iMD Companies | 2.31M |
| Hypha Labs | 2.25M |
| InVitro International | 1.90M |
| IDenta | 1.20M |